Table 1.
Characteristics of implementers of clinical pharmacogenetics (individuals and institutions) that completed the survey
Individuals (n = 15) | |
Type of Training* | n (%) |
PhD | 2 (13%) |
PharmD | 13 (87%) |
Master’s Degree | 1 (7%) |
Years Since Training Completed | |
0–5 | 6 (40%) |
6–10 | 4 (27%) |
11–15 | 3 (20%) |
16 or more | 2 (13%) |
Pharmacogenetics Training* | |
None | 2 (13%) |
Fellowship | 9 (60%) |
Master’s Degree | 1 (7%) |
Residency | 6 (40%) |
Seminars, Workshops, or CME | 5 (33%) |
Online Training | 2 (13%) |
Certificate Program | 1 (7%) |
Institutions (n = 13) | |
Type of Institution* | |
Academic | 11 (85%) |
Community | 3 (23%) |
Pharmacogenetic Testing Offered | |
Broad | 6 (46%) |
Limited | 7 (54%) |
None | 0 (0%) |
More than one answer allowed
CME = continuing medical education